Corcept Therapeutics Incorporated Stock Price on February 14, 2022

CORT Stock  USD 25.19  0.13  0.51%   
Below is the normalized historical share price chart for Corcept Therapeutics Incorporated extending back to April 14, 2004. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Corcept Therapeutics stands at 25.19, as last reported on the 29th of March, with the highest price reaching 25.69 and the lowest price hitting 25.19 during the day.
IPO Date
14th of April 2004
200 Day MA
26.4241
50 Day MA
23.3766
Beta
0.472
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
If you're considering investing in Corcept Stock, it is important to understand the factors that can impact its price. We consider Corcept Therapeutics not too volatile. Corcept Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0366, which signifies that the company had a 0.0366% return per unit of risk over the last 3 months. We have found twenty-two technical indicators for Corcept Therapeutics Incorporated, which you can use to evaluate the volatility of the firm. Please confirm Corcept Therapeutics' Mean Deviation of 2.77, risk adjusted performance of (0.03), and Standard Deviation of 4.61 to double-check if the risk estimate we provide is consistent with the expected return of 0.13%.
  
At this time, Corcept Therapeutics' Total Stockholder Equity is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 652.6 M in 2024, whereas Other Stockholder Equity is likely to drop slightly above 98.3 M in 2024. . At this time, Corcept Therapeutics' Price Earnings Ratio is comparatively stable compared to the past year. Price Book Value Ratio is likely to gain to 7.52 in 2024, whereas Price To Sales Ratio is likely to drop 7.15 in 2024. Corcept Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0366

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskCORTHuge Risk
Negative Returns

Estimated Market Risk

 3.48
  actual daily
30
70% of assets are more volatile

Expected Return

 0.13
  actual daily
2
98% of assets have higher returns

Risk-Adjusted Return

 0.04
  actual daily
2
98% of assets perform better
Based on monthly moving average Corcept Therapeutics is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Corcept Therapeutics by adding it to a well-diversified portfolio.
Price Book
5.1503
Enterprise Value Ebitda
20.4444
Price Sales
5.4057
Shares Float
84.9 M
Wall Street Target Price
42.8

Corcept Therapeutics Valuation on February 14, 2022

It is possible to determine the worth of Corcept Therapeutics on a given historical date. On February 14, 2022 Corcept was worth 22.8 at the beginning of the trading date compared to the closed value of 24.0. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Corcept Therapeutics stock. Still, in general, we apply an absolute valuation method to find Corcept Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Corcept Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Corcept Therapeutics' related companies.
 Open High Low Close Volume
03/15/2022
  22.80    24.00    22.73    24.00    726,600  
  24.00    24.35    23.58    24.24    547,000  
Backtest Corcept Therapeutics  |  Corcept Therapeutics History  |  Corcept Therapeutics Valuation Next  
Open Value
22.8
24.0
Closing Value
33.25
Upside

Corcept Therapeutics Trading Date Momentum on February 14, 2022

The event impact on price volatility cannot be determined at this time. Please check this event after some time to allow current data to be analyzed.

Corcept Therapeutics Fundamentals Correlations and Trends

By evaluating Corcept Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Corcept Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Corcept financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Corcept Therapeutics Stock history

Corcept Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Corcept is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Corcept Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Corcept Therapeutics stock prices may prove useful in developing a viable investing in Corcept Therapeutics
Last ReportedProjected for 2024
Common Stock Shares Outstanding111.7 M83.1 M
Net Income Applicable To Common Shares116.5 M122.3 M

Corcept Therapeutics Quarterly Net Working Capital

354.13 Million

Corcept Therapeutics Stock Technical Analysis

Corcept Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Corcept Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Corcept Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Corcept Therapeutics Period Price Range

Low
March 15, 2022
1.20  5.26%
High

 22.80 

     

 24.00 

Corcept Therapeutics March 29, 2024 Market Strength

Market strength indicators help investors to evaluate how Corcept Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Corcept Therapeutics shares will generate the highest return on investment. By undertsting and applying Corcept Therapeutics stock market strength indicators, traders can identify Corcept Therapeutics Incorporated entry and exit signals to maximize returns

Corcept Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Corcept Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Corcept Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Corcept to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Corcept Therapeutics is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Corcept Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Corcept Therapeutics Incorporated Stock. Highlighted below are key reports to facilitate an investment decision about Corcept Therapeutics Incorporated Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Corcept Therapeutics Incorporated. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Complementary Tools for Corcept Stock analysis

When running Corcept Therapeutics' price analysis, check to measure Corcept Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Corcept Therapeutics is operating at the current time. Most of Corcept Therapeutics' value examination focuses on studying past and present price action to predict the probability of Corcept Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Corcept Therapeutics' price. Additionally, you may evaluate how the addition of Corcept Therapeutics to your portfolios can decrease your overall portfolio volatility.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Commodity Directory
Find actively traded commodities issued by global exchanges
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Is Corcept Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Corcept Therapeutics. If investors know Corcept will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Corcept Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.995
Earnings Share
0.94
Revenue Per Share
4.658
Quarterly Revenue Growth
0.314
Return On Assets
0.1113
The market value of Corcept Therapeutics is measured differently than its book value, which is the value of Corcept that is recorded on the company's balance sheet. Investors also form their own opinion of Corcept Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Corcept Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Corcept Therapeutics' market value can be influenced by many factors that don't directly affect Corcept Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Corcept Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Corcept Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Corcept Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.